Background: Asthma is a common long-term inflammatory disease of the airways of the lungs. It is characterized by variable and recurring symptoms, reversible airflow obstruction, and bronchospasm. Sympathomimetic beta-2 agonists are the main stay of therapy of acute bronchial asthma. The present study was conducted to assess the asthmatic patients treated with salbutamol. Materials & Methods: The present study was conducted on 110 asthmatic patients of both genders. All were prescribed salbutamol for the period of 2 months and all patients were recalled and parameters such as symptoms, side effects were recorded. Results: Out of 110 patients, males were 60 and females were 50. The difference was non- significant (P- 1). Common symptoms were wheezing (105) followed by chest tightness (100), coughing (95) and shortness of breath (78). The difference was non- significant (P> 0.05). 13 patients had dizziness, 10 had migraine headache and 8 had high blood pressure with salbutamol. The difference was significant (P< 0.05). Conclusion: Asthma is a common bronchial disease affecting significant amount of population. Salbutamol is commonly employed drug found affective in most of the cases.
Key words: Asthma, Bronchospasm, Salbutamol.
Corresponding author: Dr. G.V. Diwakar, Senior Specialist (MD, Chest & TB), M.G. Hospital, Bhilwara, Rajasthan, India.
This article may be cited as: Suneja VP. Assessment of Asthmatic Patients Treated with Salbutamol: A Hospital Based Study .J Adv Med Dent Scie Res 2018;6(4):20-22.